Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cardax

Cardax
2006 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
CDXI STOCK SYMBOL
$0.20 SHARE PRICE (As of Wednesday Closing)
Description

Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has application in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. The company receives revenue from the sale of its products through e-commerce and wholesale channels.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 2800 Woodlawn Drive
  • Suite 129
  • Honolulu, HI 96822
  • United States

+1 (808) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cardax’s full profile, request a free trial.

Cardax Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.17 - $0.34 $26M $0.20 -$0.03 16.7K 133M

Cardax Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 26,253 16,770 8,920 18,241
Revenue 1,249 610 35 0
EBITDA (3,833) (1,956) (1,754) (4,234)
Net Income (3,865) (1,985) (1,784) (4,258)
Total Assets 1,555 3,157 751 852
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cardax Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cardax‘s full profile, request access.

Request full access to PitchBook

Cardax Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cardax‘s full profile, request access.

Request full access to PitchBook

Cardax Executive Team (6)

Name Title Board
Seat
Contact
Info
David Watumull Co-Founder, Board Member, President & Chief Executive Officer
John Russell Chief Financial Officer & Treasurer
David Watumull Chief Operating Officer
Gilbert Rishton Ph.D Chief Scientific Officer
Timothy King Ph.D Vice President, Research
You’re viewing 5 of 6 executives. Get the full list »

Cardax Board Members (5)

Name Representing Role Since Contact
Info
00000 00000000 Cardax Co-Founder, Board Member, President & Chief Executive Officer 000 0000
000000 00000000000 000 Self Chairman & Independent Director 000 0000
0000000 00000 00 Cardax Board of Director 000 0000
00000 000000 Self Director 000 0000
0000000 00000 00.0 Self Independent Director 000 0000